Debt to Capital Ratio: A measurement of a company's financial leverage, calculated as the company's long-term debt divided by its total capital. Calculated as: Total Long-Term Debt / (Total Long-Term Debt + Shareholders Equity)
Theriva Biologics, Inc. (TOVX) had Debt to Capital Ratio of 0.10 for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
$-3.51M |
|
-- |
|
-- |
|
$2.06M |
|
$-2.06M |
|
$0.07M |
|
$-2.00M |
|
$-2.00M |
|
$-2.00M |
|
$-2.00M |
|
$-2.00M |
|
$-2.00M |
|
$-2.06M |
|
$-2.04M |
|
12.14M |
|
12.14M |
|
$1.85 |
|
$1.85 |
|
| Balance Sheet Financials | |
$17.47M |
|
$0.22M |
|
$20.77M |
|
$38.24M |
|
$10.01M |
|
$1.67M |
|
$12.84M |
|
$22.86M |
|
$15.38M |
|
$15.38M |
|
$15.38M |
|
35.69M |
|
| Cash Flow Statement Financials | |
$-16.67M |
|
$-0.04M |
|
$18.19M |
|
$11.71M |
|
$13.10M |
|
$1.40M |
|
$0.65M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.74 |
|
-- |
|
-- |
|
|
Debt to Capital Ratio |
0.10 |
0.11 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-16.70M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-12.98% |
|
-12.98% |
|
-5.22% |
|
-11.70% |
|
$0.43 |
|
$-1.38 |
|
$-1.37 |
|